Back to Search
Start Over
PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASE
- Source :
- Value in Health. (3):A176-A177
- Publisher :
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Details
- Language :
- English
- ISSN :
- 10983015
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi.dedup.....df2563fb5e7c43fd225666125966a6da
- Full Text :
- https://doi.org/10.1016/j.jval.2011.02.975